These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9554570)

  • 1. Intermittent calcitriol therapy and growth in children with chronic renal failure.
    Kuizon BD; Salusky IB
    Miner Electrolyte Metab; 1998; 24(4):290-5. PubMed ID: 9554570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy.
    Goodman WG; Ramirez JA; Belin TR; Chon Y; Gales B; Segre GV; Salusky IB
    Kidney Int; 1994 Oct; 46(4):1160-6. PubMed ID: 7861712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD.
    Kuizon BD; Goodman WG; Jüppner H; Boechat I; Nelson P; Gales B; Salusky IB
    Kidney Int; 1998 Jan; 53(1):205-11. PubMed ID: 9453020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of intermittent calcitriol therapy on growth and secondary hyperparathyroidism.
    Salusky IB; Goodman WG; Kuizon BD
    Pediatr Nephrol; 2000 Jul; 14(7):641-5. PubMed ID: 10912534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth in children with chronic renal failure on intermittent versus daily calcitriol.
    Schmitt CP; Ardissino G; Testa S; Claris-Appiani A; Mehls O
    Pediatr Nephrol; 2003 May; 18(5):440-4. PubMed ID: 12687466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daily or intermittent calcitriol administration during growth hormone therapy in rats with renal failure and advanced secondary hyperparathyroidism.
    Sanchez CP; He YZ
    J Am Soc Nephrol; 2005 Apr; 16(4):929-38. PubMed ID: 15728789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone growth during daily or intermittent calcitriol treatment during renal failure with advanced secondary hyperparathyroidism.
    Sanchez CP; He YZ
    Kidney Int; 2007 Sep; 72(5):582-91. PubMed ID: 17554252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcitriol pulse therapy is not more effective than daily calcitriol therapy in controlling secondary hyperparathyroidism in children with chronic renal failure. European Study Group on Vitamin D in Children with Renal Failure.
    Ardissino G; Schmitt CP; Testa S; Claris-Appiani A; Mehls O
    Pediatr Nephrol; 2000 Jul; 14(7):664-8. PubMed ID: 10912539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of endochondral bone formation: roles of growth hormone, 1,25-dihydroxyvitamin D and hyperparathyroidism.
    Sanchez CP
    Pediatr Nephrol; 2000 Jul; 14(7):646-9. PubMed ID: 10912535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of secondary hyperparathyroidism during oral calcitriol therapy in pediatric renal osteodystrophy.
    Goodman WG; Salusky IB
    Contrib Nephrol; 1991; 90():189-95. PubMed ID: 1959345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcitriol administration in end-stage renal disease: intravenous or oral?
    Quarles LD; Indridason OS
    Pediatr Nephrol; 1996 Jun; 10(3):331-6. PubMed ID: 8792399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vitamin D "pulse" therapy for secondary hyperparathyroidism due to long-term hemodialysis in patients with chronic kidney failure].
    Akiba T
    Nihon Rinsho; 1991 Dec; 49 Suppl():720-4. PubMed ID: 1808342
    [No Abstract]   [Full Text] [Related]  

  • 14. Which is the preferred treatment of advanced hyperparathyroidism in a renal patient? I. Medical intervention is the primary option in the treatment of advanced hyperparathyroidism in chronic renal failure.
    Gallieni M; Brancaccio D
    Nephrol Dial Transplant; 1994; 9(12):1816-9. PubMed ID: 7708274
    [No Abstract]   [Full Text] [Related]  

  • 15. Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis.
    Greenbaum LA; Grenda R; Qiu P; Restaino I; Wojtak A; Paredes A; Benador N; Melnick JZ; Williams LA; Salusky IB
    Pediatr Nephrol; 2005 May; 20(5):622-30. PubMed ID: 15785941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of daily and intermittent-dose calcitriol on serum parathyroid hormone and ionized calcium concentrations in normal cats and cats with chronic renal failure.
    Hostutler RA; DiBartola SP; Chew DJ; Nagode LA; Schenck PA; Rajala-Schultz PJ; Drost WT
    J Vet Intern Med; 2006; 20(6):1307-13. PubMed ID: 17186842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD.
    Quarles LD; Yohay DA; Carroll BA; Spritzer CE; Minda SA; Bartholomay D; Lobaugh BA
    Kidney Int; 1994 Jun; 45(6):1710-21. PubMed ID: 7933819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D therapy in children on dialysis.
    Wesseling K; Salusky IB
    Perit Dial Int; 2007; 27(6):651-3. PubMed ID: 17984426
    [No Abstract]   [Full Text] [Related]  

  • 19. [Intravenous calcitriol in the treatment of the refractory secondary hyperparathyroidism of terminal chronic kidney failure].
    Almirall J; Torregrosa V; Arrizabalaga P; Cases A; Oliva J
    Med Clin (Barc); 1994 Mar; 102(9):325-8. PubMed ID: 8164458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulse oral calcitriol for the treatment of hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis: preliminary observations.
    Martin KJ; Ballal HS; Domoto DT; Blalock S; Weindel M
    Am J Kidney Dis; 1992 Jun; 19(6):540-5. PubMed ID: 1595702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.